>>> US Research Calls

Research Calls I
  • Upgrades:
    • Amicus Therapeutics (FOLD) upgraded to Buy from Neutral at Guggenheim; tgt $13
    • Atmos Energy (ATO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $132
    • Boston Beer Co (SAM) upgraded to Buy from Hold at Jefferies; tgt raised to $360
    • CG Oncology (CGON) upgraded to Buy from Neutral at Goldman; tgt $50
    • Edison (EIX) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $86
    • Enhabit Inc. (EHAB) upgraded to Market Perform from Underperform at Leerink Partners; tgt $8.50
    • Expeditors Intl (EXPD) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $112
    • Fortrea (FTRE) upgraded to Outperform from Neutral at Robert W. Baird; tgt lowered to $36
    • Fulcrum Therapeutics (FULC) upgraded to Buy from Neutral at Goldman; tgt $15
    • Legacy Housing (LEGH) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $25
    • Newell Brands (NWL) upgraded to Equal Weight from Underweight at Barclays; tgt $8
    • Planet Fitness (PLNT) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $78
    • Sarepta Therapeutics (SRPT) upgraded to Outperform from Perform at Oppenheimer; tgt $180
    • VTEX (VTEX) upgraded to Overweight from Neutral at JP Morgan; tgt $9
    • Expro Group (XPRO) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $27
  • Downgrades:
    • AirSculpt Technologies (AIRS) downgraded to Market Perform from Outperform at Leerink Partners; tgt lowered to $5
    • Augmedix (AUGX) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $1.50
    • Inotiv (NOTV) downgraded to Hold from Buy at Jefferies; tgt lowered to $3.75
    • Medical Properties Trust (MPW) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $5
    • Oceaneering Intl (OII) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $21
    • RAPT Therapeutics (RAPT) downgraded to Peer Perform from Outperform at Wolfe Research
    • Roblox (RBLX) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $35
  • Others:
    • Actinum Pharma (ATNM) initiated with a Overweight at Stephens; tgt $25
    • Arcellx (ACLX) initiated with an Outperform at Evercore ISI; tgt $85
    • BioMarin Pharmaceutical (BMRN) initiated with a Outperform at Evercore ISI; tgt $113
    • BioNTech (BNTX) initiated with a In-line at Evercore ISI; tgt $100
    • Blueprint Medicines (BPMC) initiated with a Overweight at Stephens; tgt $140
    • BridgeBio Pharma (BBIO) initiated with an Outperform at Evercore ISI; tgt $50
    • CRH Plc. (CRH) initiated with a Outperform at RBC Capital Mkts; tgt $110
    • CEMEX S.A. (CX) initiated with a Underperform at RBC Capital Mkts; tgt $9
    • Delcath (DCTH) initiated with a Overweight at Stephens; tgt $25
    • Descartes (DSGX) initiated with a Neutral at Redburn Atlantic; tgt $90
    • Elevation Oncology (ELEV) initiated with a Overweight at Stephens; tgt $8
    • Exelixis (EXEL) initiated with an Equal-Weight at Stephens; tgt $23
    • Inovio Pharma (INO) initiated with a Overweight at Stephens; tgt $20
    • Manhattan Assoc (MANH) initiated with a Buy at Redburn Atlantic; tgt $260
    • Moderna (MRNA) initiated with a In-line at Evercore ISI; tgt $120
    • Neurocrine Biosciences (NBIX) initiated with an Outperform at Evercore ISI; tgt $175
    • Blue Owl Capital (OWL) resumed with a Buy at Citigroup; tgt $21
    • Regeneron Pharma (REGN) initiated with an Outperform at Evercore ISI; tgt $1150
    • Seagate Tech (STX) initiated with a Buy at Citigroup; tgt $110
    • Sensei Biotherapeutics (SNSE) initiated with a Overweight at Stephens; tgt $5
    • SPS Commerce (SPSC) initiated with a Buy at Redburn Atlantic; tgt $220
    • Veru (VERU) initiated with a Buy at B. Riley Securities; tgt $5
    • Vermilion Energy (VET) resumed with a Outperform at BMO Capital Markets
    • Weatherford (WFRD) initiated with a Buy at Citigroup; tgt $155
    • Western Digital (WDC) initiated with a Buy at Citigroup; tgt $90